Dasatinib as a treatment for Duchenne muscular dystrophy

Lipscomb, L., Piggott, R.W., Emmerson, T. et al. (1 more author) (2016) Dasatinib as a treatment for Duchenne muscular dystrophy. Human Molecular Genetics, 25 (2). pp. 266-274. ISSN 0964-6906



  • Lipscomb, L.
  • Piggott, R.W.
  • Emmerson, T.
  • Winder, S.J.
Copyright, Publisher and Additional Information: © The Author 2015. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
  • Published: 15 January 2016
  • Published (online): 24 November 2015
  • Accepted: 9 November 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biological Sciences (Sheffield) > Department of Biomedical Science (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 08 Aug 2016 11:52
Last Modified: 08 Aug 2016 11:52
Published Version: http://dx.doi.org/10.1093/hmg/ddv469
Status: Published
Publisher: Oxford University Press
Refereed: Yes
Identification Number: https://doi.org/10.1093/hmg/ddv469
Related URLs:

Share / Export